These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 7870047

  • 21. Molecular determinants of proton-sensitive N-methyl-D-aspartate receptor gating.
    Low CM, Lyuboslavsky P, French A, Le P, Wyatte K, Thiel WH, Marchan EM, Igarashi K, Kashiwagi K, Gernert K, Williams K, Traynelis SF, Zheng F.
    Mol Pharmacol; 2003 Jun; 63(6):1212-22. PubMed ID: 12761330
    [Abstract] [Full Text] [Related]

  • 22. The NMDA receptor complex: a long and winding road to therapeutics.
    Wood PL.
    IDrugs; 2005 Mar; 8(3):229-35. PubMed ID: 15772895
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Pharmacological implications of two distinct mechanisms of interaction of memantine with N-methyl-D-aspartate-gated channels.
    Chen HS, Lipton SA.
    J Pharmacol Exp Ther; 2005 Sep; 314(3):961-71. PubMed ID: 15901795
    [Abstract] [Full Text] [Related]

  • 27. Mechanism of partial agonist action at the NR1 subunit of NMDA receptors.
    Inanobe A, Furukawa H, Gouaux E.
    Neuron; 2005 Jul 07; 47(1):71-84. PubMed ID: 15996549
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Single channel analysis of a novel NMDA channel from Xenopus oocytes expressing recombinant NR1a, NR2A and NR2D subunits.
    Cheffings CM, Colquhoun D.
    J Physiol; 2000 Aug 01; 526 Pt 3():481-91. PubMed ID: 10922001
    [Abstract] [Full Text] [Related]

  • 30. Cloning and functional characterization of human heteromeric N-methyl-D-aspartate receptors.
    Hess SD, Daggett LP, Crona J, Deal C, Lu CC, Urrutia A, Chavez-Noriega L, Ellis SB, Johnson EC, Veliçelebi G.
    J Pharmacol Exp Ther; 1996 Aug 01; 278(2):808-16. PubMed ID: 8768735
    [Abstract] [Full Text] [Related]

  • 31. Subtype-selective antagonism of N-methyl-D-aspartate receptors by felbamate: insights into the mechanism of action.
    Kleckner NW, Glazewski JC, Chen CC, Moscrip TD.
    J Pharmacol Exp Ther; 1999 May 01; 289(2):886-94. PubMed ID: 10215667
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. A regulatory domain (R1-R2) in the amino terminus of the N-methyl-D-aspartate receptor: effects of spermine, protons, and ifenprodil, and structural similarity to bacterial leucine/isoleucine/valine binding protein.
    Masuko T, Kashiwagi K, Kuno T, Nguyen ND, Pahk AJ, Fukuchi J, Igarashi K, Williams K.
    Mol Pharmacol; 1999 Jun 01; 55(6):957-69. PubMed ID: 10347236
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.